Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab.
Saved in:
| Title: | Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab. |
|---|---|
| Authors: | Magnus CL; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany., Hiergeist A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany., Schuster P; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany., Rohrhofer A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany., Medenbach J; Biochemistry I, Faculty of Biology and Pre-Clinical Medicine, University of Regensburg, Regensburg, Germany., Gessner A; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany., Peterhoff D; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany., Schmidt B; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Aug 24; Vol. 13, pp. 966236. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36090991 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Magnus+CL%22">Magnus CL</searchLink>; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hiergeist+A%22">Hiergeist A</searchLink>; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schuster+P%22">Schuster P</searchLink>; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Rohrhofer+A%22">Rohrhofer A</searchLink>; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Medenbach+J%22">Medenbach J</searchLink>; Biochemistry I, Faculty of Biology and Pre-Clinical Medicine, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Gessner+A%22">Gessner A</searchLink>; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Peterhoff+D%22">Peterhoff D</searchLink>; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Schmidt+B%22">Schmidt B</searchLink>; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, Regensburg, Germany.; Institute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2022 Aug 24; Vol. 13, pp. 966236. <i>Date of Electronic Publication: </i>2022 Aug 24 (<i>Print Publication: </i>2022). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36090991 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.966236 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 966236 Titles: – TitleFull: Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Magnus CL – PersonEntity: Name: NameFull: Hiergeist A – PersonEntity: Name: NameFull: Schuster P – PersonEntity: Name: NameFull: Rohrhofer A – PersonEntity: Name: NameFull: Medenbach J – PersonEntity: Name: NameFull: Gessner A – PersonEntity: Name: NameFull: Peterhoff D – PersonEntity: Name: NameFull: Schmidt B IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 08 Text: 2022 Aug 24 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
